表4. 根据病因分组后各组与对照组基因型频率及等位基因频率差异比较.
| 项目 | 例数 | patatin样磷脂酶域 | 跨膜蛋白6超家族2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C(%) | G(%) | 3C/C[例(%)] | C/G[例(%)] | G/G[例(%)] | C(%) | T(%) | C/C[例(%)] | C/T[例(%)] | T/T[例(%)] | |||
| 对照组 | 164 | 69.5 | 30.5 | 79(48.2) | 70(42.7) | 15(9.1) | 95.4 | 4.6 | 150(91.5) | 13(7.9) | 1(0.6) | |
| 乙肝相关性肝癌组 | 374 | 58.7 | 41.3 | 133(35.6) | 173(46.3) | 68(18.2) | 92.6 | 7.4 | 321(85.8) | 51(13.6) | 2(0.5) | |
| 丙肝相关性肝癌组 | 109 | 63.8 | 36.2 | 47(43.1) | 45(41.3) | 17(15.6) | 92.2 | 7.8 | 93(85.3) | 15(13.8) | 1(0.9) | |
| 酒精相关性肝癌组 | 38 | 48.7 | 51.3 | 9(23.7) | 19(50.0) | 10(26.3) | 88.2 | 11.8 | 30(78.9) | 7(18.4) | 1(2.6) | |
| 乙肝相关性肝癌组与对照组比较 | ||||||||||||
| OR | 1 | 1.605 | 1 | 1.684 | 1 | 1.656 | 1 | 1.769 | ||||
| 95% CI | 1.217~2.116 | 1.161~2.444 | 0.921~2.977 | 0.952~3.289 | ||||||||
| P值 | 0.001 | 0.006 | 0.089 | 0.068 | ||||||||
| 丙肝相关性肝癌组与对照组比较 | ||||||||||||
| OR | 1 | 1.296 | 1 | 1.226 | 1 | 1.765 | 1 | 1.843 | ||||
| 95% CI | 0.902~1.862 | 0.753~1.996 | 0.862~3.613 | 0.860~3.951 | ||||||||
| P值 | 0.161 | 0.412 | 0.116 | 0.112 | ||||||||
| 酒精相关性肝癌组与对照组比较 | ||||||||||||
| OR | 1 | 2.403 | 1 | 2.995 | 1 | 2.803 | 1 | 2.857 | ||||
| 95% CI | 1.447~3.992 | 1.335~6.720 | 1.177~6.674 | 1.102~7.410 | ||||||||
| P值 | 0.001 | 0.006 | 0.032 | 0.052 | ||||||||